COVID-19 Immunization Update Masterclass: Advise, Protect, Prevent in Winter 2023
Thursday, 28 September 2023 | 17:00 CET
FOR HEALTHCARE PROFESSIONALS ONLY
OVERVIEW
Join our Masterclass to stay up to date on the latest developments and strategies for protecting at-risk populations in the ongoing COVID-19 pandemic. Our expert panel will delve into the science of SARS-CoV-2 to evaluate the burden of disease, compare different vaccine platforms, and explore European COVID-19 booster recommendations. This is an excellent opportunity to gain valuable insights and knowledge on mitigating the spread of the virus and safeguarding the health of the community.
This is a promotional symposium for Nuvaxovid. Event initiated, organised and funded by Novavax.
Faculty
agenda
The Nuvaxovid™ ▼ COVID-19 Vaccine (recombinant, adjuvanted)—also known as NVX-CoV2373—has been granted marketing authorisation in the European Union for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older. The vaccine should be used in accordance with official recommendations. Global information for healthcare professionals is available at: https://www.novavaxcovidvaccine.com
Click here to view the EU Summary of Product Characteristics
Suspected Adverse Events should be reported via the national reporting system which can be accessed at: https://www.novavaxcovidvaccine.com
To learn more about our privacy practices, please view our privacy policy.